These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 332637)

  • 1. Immunological interrelationships between cholera toxin and the heat-labile and heat-stable enterotoxins of coliform bacteria.
    Klipstein FA; Engert RF
    Infect Immun; 1977 Oct; 18(1):110-7. PubMed ID: 332637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological relationship of different preparations of coliform enterotoxins.
    Klipstein FA; Engert RF
    Infect Immun; 1978 Sep; 21(3):771-8. PubMed ID: 361578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological relationships between cholera toxin and Escherichia coli heat-labile enterotoxin.
    Gilligan PH; Brown JC; Robertson DC
    Infect Immun; 1983 Nov; 42(2):683-91. PubMed ID: 6196292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of jejunal water secretion by glucose in rats exposed to coliform enterotoxins.
    Klipstein FA; Engert RF
    Gastroenterology; 1978 Aug; 75(2):255-62. PubMed ID: 352789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative enterotoxigenicity of coliform bacteria.
    Klipstein FA; Engert RF; Short HB
    J Infect Dis; 1977 Aug; 136(2):205-15. PubMed ID: 330767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of shared and unique immunological determinants in enterotoxins from Vibrio cholerae and Escherichia coli.
    Clements JD; Finkelstein RA
    Infect Immun; 1978 Dec; 22(3):709-13. PubMed ID: 83301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of assay of coliform enterotoxins by conventional techniques versus in vivo intestinal perfusion.
    Klipstein FA; Guerrant RL; Wells JG; Short HB; Engert RF
    Infect Immun; 1979 Jul; 25(1):146-52. PubMed ID: 383611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity to heat-labile enterotoxins of porcine and human Escherichia coli strains achieved with synthetic cholera toxin peptides.
    Jacob CO; Arnon R; Finkelstein RA
    Infect Immun; 1986 May; 52(2):562-7. PubMed ID: 3009330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of heat-labile toxin of E. coli by antibodies to synthetic peptides derived from the B subunit of cholera toxin.
    Jacob CO; Pines M; Arnon R
    EMBO J; 1984 Dec; 3(12):2889-93. PubMed ID: 6098453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in cross-protection in rats immunized with the B subunits of cholera toxin and Escherichia coli heat-labile toxin.
    Klipstein FA; Engert RF; Clements JD; Houghten RA
    Infect Immun; 1984 Mar; 43(3):811-6. PubMed ID: 6365784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique features of heat-stable enterotoxin of Shigella flexneri.
    Kétyi I; Vertényi A; Málovics I; Kontrohr T; Pácsa S
    Acta Microbiol Acad Sci Hung; 1978; 25(3):219-27. PubMed ID: 358771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological relationship of the B subunits of Campylobacter jejuni and Escherichia coli heat-labile enterotoxins.
    Klipstein FA; Engert RF
    Infect Immun; 1985 Jun; 48(3):629-33. PubMed ID: 3922890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-neutralization reactions of Escherichia coli and Vibrio cholerae enterotoxins as studied by rabbit skin inoculation test.
    Singh A; Mohan KS; Sethi SK; Vadehra DV
    Acta Microbiol Acad Sci Hung; 1977; 24(1):33-9. PubMed ID: 337760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of special antibodies which react only with homologous enterotoxins from Vibrio cholerae and Enterotoxigenic Escherichia coli.
    Honda T; Takeda Y; Miwatani T
    Infect Immun; 1981 Nov; 34(2):333-6. PubMed ID: 6171516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenic and antigenic characteristics of Salmonella heat-labile enterotoxin.
    Kaura YK; Sharma VK
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 May; 268(3):386-404. PubMed ID: 3136609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in chemical properties and antigenic determinants among type II heat-labile enterotoxins of Escherichia coli.
    Guth BE; Twiddy EM; Trabulsi LR; Holmes RK
    Infect Immun; 1986 Nov; 54(2):529-36. PubMed ID: 2429930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proposal for safety standards for human use of cholera toxin (or Escherichia coli heat-labile enterotoxin) derivatives as an adjuvant of nasal inactivated influenza vaccine.
    Tamura SI; Kurata T
    Jpn J Infect Dis; 2000 Jun; 53(3):98-106. PubMed ID: 10957706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of 5-hydroxytryptamine type 3 receptors in rat intestinal fluid and electrolyte secretion induced by cholera and Escherichia coli enterotoxins.
    Mourad FH; O'Donnell LJ; Dias JA; Ogutu E; Andre EA; Turvill JL; Farthing MJ
    Gut; 1995 Sep; 37(3):340-5. PubMed ID: 7590428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies to Escherichia coli heat-labile enterotoxins: neutralising activity and differentiation of human and porcine LTs and cholera toxin.
    Svennerholm AM; Wikström M; Lindblad M; Holmgren J
    Med Biol; 1986; 64(1):23-30. PubMed ID: 3724258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological cross-reactivity between a heat-labile enterotoxin(s) of Escherichia coli and subunits of Vibrio cholerae enterotoxin.
    Clements JD; Finkelstein RA
    Infect Immun; 1978 Sep; 21(3):1036-9. PubMed ID: 361573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.